References
- Duncan SR, Scott S, Duncan CJ. Modelling the dynamics of scarlet fever epidemics in the 19th century. Eur J Epidemiol. 2000;16(7):619–626.
- Katz AR, Morens DM. Severe streptococcal infections in historical perspective. Clin Infect Dis. 1992;14(1):298–307.
- Mayfield JA, Liang Z, Agrahari G, et al. Mutations in the control of virulence sensor gene from Streptococcus pyogenes after infection in mice lead to clonal bacterial variants with altered gene regulatory activity and virulence. PLoS One. 2014;9(6):e100698.
- Hollands A, Pence MA, Timmer AM, et al. Genetic switch to hypervirulence reduces colonization phenotypes of the globally disseminated group A streptococcus M1T1 clone. J Infect Dis. 2010;202(1):11–19.
- Eriksson BK, Villasenor-Sierra A, Norgren M, et al. Opsonization of T1M1 group A Streptococcus: dynamics of antibody production and strain specificity. Clin Infect Dis. 2001;32(2):E24–E30.
- de Malmanche SA, Martin DR. Protective immunity to the group A Streptococcus may be only strain specific. Med Microbiol Immunol. 1994;183(6):299–306.
- Duan Y, Huang XL, Wang YJ, et al. Impact of meteorological changes on the incidence of scarlet fever in Hefei City, China. Int J Biometeorol. 2016. doi:10.1007/s00484-016-1145-8. [Epub ahead of print].
- Guy R, Williams C, Irvine N, et al. Increase in scarlet fever notifications in the United Kingdom, 2013/2014. Euro Surveill. 2014;19(12):20749.
- Ben Zakour NL, Davies MR, You Y, et al. Transfer of scarlet fever-associated elements into the group A Streptococcus M1T1 clone. Sci Rep. 2015;5:15877.
- Lau EH, Nishiura H, Cowling BJ, et al. Scarlet fever outbreak, Hong Kong, 2011. Emerg Infect Dis. 2012;18(10):1700–1702.
- Tse H, Bao JY, Davies MR, et al. Molecular characterization of the 2011 Hong Kong scarlet fever outbreak. J Infect Dis. 2012;206(3):341–351.
- Chen M, Yao W, Wang X, et al. Outbreak of scarlet fever associated with emm12 type group A Streptococcus in 2011 in Shanghai, China. Pediatr Infect Dis J. 2012;31(9):e158–e162.
- Wong SS, Yuen KY. Streptococcus pyogenes and re-emergence of scarlet fever as a public health problem. Emerg Microbes Infect. 2012;1(7):e2.
- Espinosa de los Monteros LE, Bustos IM, Flores LV, et al. Outbreak of scarlet fever caused by an erythromycin-resistant Streptococcus pyogenes emm22 genotype strain in a day-care center. Pediatr Infect Dis J. 2001;20(8):807–809.
- Davies MR, Holden MT, Coupland P, et al. Emergence of scarlet fever Streptococcus pyogenes emm12 clones in Hong Kong is associated with toxin acquisition and multidrug resistance. Nat Genet. 2015;47(1):84–87.
- Turner CE, Abbott J, Lamagni T, et al. Emergence of a new highly successful Acapsular Group A Streptococcus Clade of Genotype emm89 in the United Kingdom. MBio. 2015;6(4):e00622.
- Dowson CG, Barcus V, King S, et al. Horizontal gene transfer and the evolution of resistance and virulence determinants in Streptococcus. Soc Appl Bacteriol Symp Ser. 1997;26:42S–51S.
- Yu CE, Ferretti JJ. Molecular epidemiologic analysis of the type A streptococcal exotoxin (erythrogenic toxin) gene (speA) in clinical Streptococcus pyogenes strains. Infect Immun. 1989;57(12):3715–3719.
- Silva-Costa C, Carrico JA, Ramirez M, et al. Scarlet fever is caused by a limited number of Streptococcus pyogenes lineages and is associated with the exotoxin genes ssa, speA and speC. Pediatr Infect Dis J. 2014;33(3):306–310.
- Chiappini E, Regoli M, Bonsignori F, et al. Analysis of different recommendations from international guidelines for the management of acute pharyngitis in adults and children. Clin Ther. 2011;33(1):48–58.